Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Thu, 13.08.2026       https://research-hub.de/companies/formycon-ag

Formycon's H1 2026 results showed strong year-on-year growth, with revenue nearly tripling to EUR 25.8m and EBITDA improving to EUR -3.4m. FYB206 licensing income was the main driver, delivering a consistent contribution across both quarters, while FYB202 royalties trended higher off a low base, though below management's own expectations. On the pipeline side, FYB203 launched in Europe and prepares for its US entry in Q4, FYB201/Cimerli continues its gradual US recovery via Sandoz, and FYB206 clinical development was completed, moving toward regulatory submission. Management confirmed FY2026 guidance. We maintain our BUY rating and EUR 38.00 price target. The full update can be downloaded under https://research-hub.de/companies/formycon-ag
Wed, 12.08.2026       GFT TEchnologies SE

Company Name: GFT TEchnologies SE ISIN: DE0005800601   Reason for the research: Update Recommendation: Buy from: 12.08.2026 Target price: 35 Last rating change: Analyst: Sebastian Droste Brazil and AI drive solid growth On August 6, GFT released its H1 financial results and confirmed its guidance for 2026. Revenue growth was stab [ … ]
Wed, 12.08.2026       https://research-hub.de/companies/viscom-se

Viscom’s Q2 marked a clear operational improvement, with a sharp return to profitability on recovering volumes, improving mix and strong operating leverage, while positive operating cash flow added further support. Importantly, the recovery is not confined to the battery project: core SMT, industrial and automotive demand is improving, led by Asia and North America, while Europe remains subdued. With orderintake guidance looking achievable, a backlog underpinning H2 and potential upside from earlier battery deliveries, full-year delivery now appears materially more credible. At the same time, pricing pressure, weaker service revenues and still-subnormal gross margins remain the key watchpoints. Overall, we see execution risk declining and the setup into 2027 improving, supporting our BUY rating and EUR 8.00 price target. The full update can be downloaded under https://research-hub.de/companies/viscom-se
Wed, 12.08.2026       https://research-hub.de/companies/singulus-technologies-ag

Q2 was operationally encouraging, with strong yoy revenue growth, better gross margins and a return to positive EBIT, but the sharp slowdown in order intake tempers the near-term upside and reinforces the importance of renewed order momentum. The MASS acquisition adds strategically relevant capabilities at limited financial risk, while the existing backlog leaves FY26 guidance looking achievable despite still-negative cash conversion which is expected to improve into H2. With execution improving but fresh orders yet to reaccelerate, we see the risk/reward as balanced and reiterate our HOLD rating and EUR 6.00 price target. The full update can be downloaded under https://research-hub.de/companies/singulus-technologies-ag
Wed, 12.08.2026       https://research-hub.de/companies/bechtle-ag

Bechtle’s final Q2 26 results confirmed the strong preliminary figures and, importantly, provided further evidence that the acceleration is broad-based and largely organic. Order intake jumped 25.5% yoy to EUR 2.47bn and the order backlog reached a new record of EUR 3.54bn. Business volume increased 18.1% yoy to EUR 2.27bn, revenue rose 16.5% to EUR 1.73bn and EBT advanced 20.1% to EUR 80.2m. The main blemish was operating cash flow of EUR -112.5m in Q2, reflecting temporary working-capital effects related to order-backed inventories. After updating our model following the preliminary Q2 figures (read here: research-hub.de/companies/bechtle-ag), we leave our estimates unchanged. Our estimates imply a pronounced slowdown in H2 and therefore continue to offer room for additional upside. Apart from that, management reiterated on the call that the overall market environment remains difficult and challenging. However, we reiterate our BUY rating and EUR 45.00 price target. The full update can be downloaded under https://research-hub.de/companies/bechtle-ag
Wed, 12.08.2026       Multitude AG

Company Name: Multitude AG ISIN: CH1398992755   Reason for the research: Update Recommendation: BUY Target price: EUR 11.00 Target price on sight of: 12 months Last rating change: Analyst: Julius Neittamo Q2 preview; partnership business to support profitabilityMultitude will report its Q2'26 results this Thursday. Consumer Banki [ … ]
Wed, 12.08.2026       https://research-hub.de/companies/tui-ag

TUI’s Q3 26 results missed expectations, with revenue down 6.1% yoy to EUR 5,822m and underlying EBIT down 27% yoy to EUR 234m (vs. EUR 291m consensus), hit by EUR 20m in direct Iran conflict costs and elevated jet fuel prices. Holiday Experiences remained relatively stable, but Markets + Airline swung to an EBIT loss due to Middle East consumer caution and soft regional pricing, prompting a 5% risk capacity reduction. Delayed deposits drove working capital shifts, missing consensus at FCF and net debt. While Summer 2026 bookings lag at -6% yoy, a late +7% last 4 weeks rebound supports reaffirmed FY26 EBIT guidance (EUR 1.1bn - 1.4bn). However, persistent geopolitical risks and lower visibility lead us to trim estimates, reducing our target price to EUR 13.50 (from EUR 15.00) while maintaining a BUY rating. The full update can be downloaded under https://research-hub.de/companies/tui-ag
Wed, 12.08.2026       https://research-hub.de/companies/thyssenkrupp-nucera-ag-co-kgaa

tk nucera’s Q3 FY26 results were in line with preliminary figures, with weaker Green Hydrogen revenues offset by better gross margins, cost discipline and a resilient ChlorAlkali business. While cash generation remained soft, the company continues to benefit from a very strong balance sheet and high net cash. Encouragingly, order momentum improved significantly, supported by the large-scale project in Spain, underlining that major hydrogen projects can return quickly once investment decisions are taken. Management also narrowed FY26 guidance following the decision to discontinue proprietary SOEC mass production. We view this step as strategically sensible, as it improves capital discipline and sharpens the focus on core technologies. We slightly adjust our FY26 estimates to reflect the refined guidance and SOEC-related one-offs, while leaving our medium-term assumptions unchanged. We reiterate our BUY rating and EUR 15.00 PT. On September 15, the company will provide deeper insights into its outlook at our Future of Energy online conference, with free registration available here: https://research-hub.de/events/registration/2026-09-15-11-00/NCH2-GR The full update can be downloaded under https://research-hub.de/companies/thyssenkrupp-nucera-ag-co-kgaa
Wed, 12.08.2026       https://research-hub.de/companies/indus-holding-ag

INDUS Holding released its full Q2/H1 26 report, confirming strong Q2 figures while offering clearer visibility into underlying momentum. Q2 revenue rose 20.6% yoy to EUR 523.6m, and adjusted EBITA surged 160% yoy to EUR 81.1m (margin: 15.5%). While the tungsten special situation in Materials Solutions continues to drive extraordinary profitability, the detailed report highlights an encouraging sequential recovery in Engineering, strong organic growth in Infrastructure, and a robust book-to-bill ratio of 1.14x across the group. A sequential Q2 FCF rebound (+EUR 37.2m vs Q1 -EUR 74.1m) further eases working capital concerns. We reiterate our BUY rating with an unchanged PT of EUR 43.00. The full update can be downloaded under https://research-hub.de/companies/indus-holding-ag
Wed, 12.08.2026       https://research-hub.de/companies/tkms-ag-co-kgaa

TKMS reported a clean 9M beat and lifted FY25/26 guidance for the second time this year. Sales rose 19% to EUR 1,890m (mwb est. EUR 1,780m), while adjusted EBIT of EUR 110m grew 13% at a 5.8% margin and also came in above our estimate. Management now guides for revenue growth of 10-12% (prev.: 2-5%) and an adjusted EBIT margin of up to 6.5% (prev.: >6%). Interestingly, the previous reference to “backend growth acceleration” was removed from the mid-term guidance, suggesting management now expects >10% growth from here. The order backlog stood at EUR 20.1bn at the end of June, and we expect another strong step-up in Q4. A more detailed sector update on backlog will follow next week. 9M FCF of EUR 204m negative was in line with our timing expectations, with the company guiding for positive FCF for the full year. We raise our estimates and PT to EUR 140.00 (from EUR 135.00) and reiterate BUY. The full update can be downloaded under https://research-hub.de/companies/tkms-ag-co-kgaa

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 22.11.2026, Calendar Week 47, 326th day of the year, 39 days remaining until EoY.